Michael Rogers | CFO |
Steve Hoffman | CEO |
Steve Pakola | CMO |
Eliana Merle | Cantor Fitzgerald |
Jonathan Aschoff | National Securities |
Adnan Butt | Guggenheim Securities |
Yi Chen | H.C. Wainwright |
Good morning, ladies and gentlemen. Thank you for standing by and welcome to Aerpio Pharmaceuticals’ Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference Call. It is now my pleasure to turn the call over to Michael Rogers, Aerpio's Chief Financial Officer. Please go ahead, sir.
Okay, Demetrius.